SCHEMBL13428198

SCHEMBL13428198

Cc1ccc(-c2c3cc(N4c5ccccc5CCc5ccccc54)ccc3c(-c3cccc4ccccc34)c3cc(N4c5ccccc5CCc5ccccc54)ccc23)cc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2D6 P10635 1/20 0.33
FPR1 P21462 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
APC P25054 1/20 0.32
EGFR P00533 2/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13427068 0.94 HTR7 (0.35) HTR7MEN1KMT2ANPSR1KDM4E
SCHEMBL13428196 0.89 MAPT (0.36) MEN1KMT2ANPSR1KDM4ECYP1A2
SCHEMBL13008432 0.89
SCHEMBL13008454 0.88 NPSR1 (0.38) MEN1KMT2ANPSR1KDM4ECYP1A2
SCHEMBL13008450 0.88 CYP1A2 (0.36) MEN1KMT2AKDM4ECYP1A2CYP2C9
SCHEMBL13428185 0.88 HDAC8 (0.35) HTR7KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL13008456 0.88 CYP1A2 (0.35) HTR7MEN1KMT2ANPSR1KDM4E
SCHEMBL13009166 0.88 POLB (0.38) HTR7NPSR1KDM4ECYP1A2CYP2C9
SCHEMBL13008776 0.87 MEN1 (0.36) HTR7MEN1KMT2AKDM4ECA12
SCHEMBL13428194 0.87 POLB (0.34) HTR7MEN1KMT2ANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A HTR7 3454/4885MEN1 3994/4885KMT2A 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.